Browsing Øvrige samlinger by Author "Usmani, Saad"

Now showing items 1-2 of 2

  • International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders 
    Hillengass, Jens; Usmani, Saad; Rajkumar, S. Vincent; Durie, Brian G.M.; Mateos, María-Victoria; Lonial, Sagar; Joao, Cristina; Anderson, Kenneth C.; García-Sanz, Ramón; Serra, Eloísa Riva; Du, Juan; van de Donk, Niels; Berdeja, Jesús G.; Terpos, Evangelos; Zamagni, Elena; Kyle, Robert A.; San Miguel, Jesús; Goldschmidt, Hartmut; Giralt, Sergio; Kumar, Shaji; Raje, Noopur; Ludwig, Heinz; Ocio, Enrique; Schots, Rik; Einsele, Hermann; Schjesvold, Fredrik Hellem; Chen, Wen-Ming; Abildgaard, Niels; Lipe, Brea C.; Dytfeld, Dominik; Wirk, Baldeep Mona; Drake, Matthew; Cavo, Michele; Lahuerta, Juan José; Lentzsch, Suzanne (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2019)
    Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the investigation of multiple myeloma and often ...
  • Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage 
    Fernández de Larrea, Carlos; Kyle, RA; Rosiñol, Laura; Paiva, Bruno; Engelhardt, Monika; Usmani, Saad; Caers, Jo; Gonsalves, Wilson; Schjesvold, Fredrik Hellem; Merlini, Giampaolo; Lentzch, Suzanne; Ocio, Enrique; Garderet, Laurent; Moreau, Philippe; Sonneveld, Pieter; Badros, Ashraf; Gahrton, Gösta; Goldschmidt, Hartmut; Tuchman, Sascha; Einsele, Hermann; Durie, Brian; Wirk, Baldeep Mona; Musto, Pellegrino; Hayden, Patrick; Kaiser, Martin; Miguel, Jesús San; Bladé, Joan; Rajkumar, S. Vincent; Mateos, Maria Victoria (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Abstract Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progress in the last decades. PCL deserves a prompt identification to start the most effective treatment for this ultra-high-risk ...